Tags: Drug.

Solithromycin (formerly known as CEM-101 and OP-1068) is a novel ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections. It is expected to be the first macrolide antibiotic available in intravenous oral and pediatric suspension formulations in over 20 years.Solithromycin exhibits excellent in vitro activity against a broad spectrum of Gram-positive respiratory tract pathogens including macrolide-resistant strains.

Solithromycin.svg
ATC prefix
none
CAS number
760981-83-7
FDA UNII code
9U1ETH79CK
IUPAC name
(3aS4R7S9R10R11R13R15R15aR)-1-[4-[4-(3-aminophenyl)-1H-123-triazol-1-yl]butyl]-4-ethyl-7-fluorooctahydro-11-methoxy-3a79111315-hexamethyl-10-[346-trideoxy-3-(dimethylamino)-β-(D)-xylo-hexopyranosyl]oxy-2H-Oxacyclotetradecino[43-d]oxazole-26814(1H7H9H)-tetrone

Loading...

This page contains content from the copyrighted Wikipedia article "Solithromycin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.